City University of New York (CUNY)

CUNY Academic Works
Publications and Research

City College of New York

2019

Public Health Research Priorities to Address Female Genital
Mutilation or Cutting in the United States
Holly G. Atkinson
CUNY City College

Deborah Ottenheimer
Icahn School of Medicine at Mount Sinai

Ranit Mishori
Georgetown University School of Medicine

How does access to this work benefit you? Let us know!
More information about this work at: https://academicworks.cuny.edu/cc_pubs/774
Discover additional works at: https://academicworks.cuny.edu
This work is made publicly available by the City University of New York (CUNY).
Contact: AcademicWorks@cuny.edu

AJPH PERSPECTIVES

Public Health Research Priorities to Address
Female Genital Mutilation or Cutting in the United
States
Female genital mutilation or cutting (FGM/C), an age-old tradition
that is still widely practiced around
the world, is gaining recognition
as an important public health issue
in the United States. Increasingly,
because of migration, women and
girls affected by FGM/C have become members of host communities where the practice is not
culturally acceptable.
According to recent conservative estimates, more than 513 000
immigrant women and girls living
in the United States have undergone or are at risk for FGM/C, a
signiﬁcant increase from the 1990
estimate of 168 000. The arrests
of physicians in Michigan in 2017
for performing FGM/C on minors
underscores the fact that cutting
is happening in the United States.
We have identiﬁed numerous
gaps in our understanding of the
magnitude of the problem in the
United States and in the availability of scientiﬁc data informing
a variety of interventions (preventive, clinical, educational, legal). We catalog these major gaps
and propose a research agenda
that can help public health experts, researchers, clinicians, and
other stakeholders to establish
priorities as we confront FGM/C as
an important health issue affecting
hundreds of thousands of women
and girls in the United States. (Am J
Public Health. 2019;109:1523–1527.
doi:10.2105/AJPH.2019.305259)
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T

he World Health Organization (WHO) has deﬁned
female genital mutilation or
cutting (FGM/C) as “all procedures that involve partial or
total removal of the external female genitalia, or other injury to
the female genital organs, for
non-medical reasons,” and has
classiﬁed FGM/C into four
fundamental types (with several
subclassiﬁcations added in 2016.)1
FGM/C is practiced around the
world, primarily in Africa (e.g.,
Somalia, Guinea), the Middle
East (e.g., Iraq, Yemen) and
Southeast Asia (e.g., Indonesia).2
Increasingly, because of migration, women and girls affected by
FGM/C have become members
of societies where the practice is
not normative, including the
United States.
In October 2018, a federal
judge in Michigan ruled that the
1996 US federal law banning
FGM/C is unconstitutional, and
dismissed key charges against two
physicians accused of performing
FGM/C on upwards of 100 girls
from several states.3 The ruling
has rattled survivors and antiFGM/C advocates, putting the
legal battle to ban FGM/C, even
in the US context, front and
center. Past media reports have
publicized the arrests of parents
in the United States who have
undertaken the cutting of their
daughters’ genitalia.4 There have
also been reports of traditional
cutters performing FGM/C on
girls living in America.5 In part

because of the media coverage of
these cases, as well as outreach
efforts by the US Department of
Justice following the Michigan
case, the medical community has
become increasingly aware of the
knowledge gaps and complex
issues facing health care providers
with respect to FGM/C. This has
led to an enhanced interest in
exploring the evidence regarding
prevention of the practice, management of its consequences, and
culturally appropriate support
of affected women and girls.
In collaboration with colleagues, we have identiﬁed
numerous gaps in our understanding of the magnitude of
the problem in the United States
and in the availability of data
informing a variety of interventions (clinical, educational, legal,
etc.). In this commentary, we
catalog these major gaps and propose a research agenda that can
help establish priorities as we
confront FGM/C as a public
health issue in the United States.
Our research agenda (see the box
on page 1524) is informed by a
narrative review of the literature, a
consideration of WHO priorities,

and a synthesis of the conclusions
of the US Network to End
FGM/C: Health Care Working
Group at the End Violence Against
Girls: Summit on FGM/C in
December 2016.

RESEARCH PRIORITIES
We have identiﬁed seven research priorities.

Prevalence and Incidence
Although the exact number of
girls and women globally who
have experienced FGM/C remains unknown, more than 200
million girls and women in 30
countries are estimated to have
undergone FGM/C, on the
basis of data from countrywide
surveys.2,6 In some practicing
countries FGM/C is widespread,
affecting the vast majority of the
female population, whereas in
other countries FGM/C is practiced only among subpopulations, affecting a far smaller
percentage of women and girls.2
A challenge to addressing
FGM/C in the United States is
the absence of an accurate count
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PROPOSED RESEARCH PRIORITIES FOR FEMALE GENITAL MUTILATION OR CUTTING
1. Prevalence and incidence: determine the prevalence and incidence of FGM/C in the United States with greater precision and determine the demographics of affected girls
and women and at-risk girls.
2. Identiﬁcation and screening: determine best practices to educate health care providers on accurate identiﬁcation and documentation of FGM/C types and validate screening
tools to identify at-risk girls.
3. Clinical management: identify best practices, assess their outcomes in this population, and develop best practice guidelines for clinical management of a range of FGM/C
issues and complications, including obstetrical issues, gynecological and urological problems, sexual functioning, chronic pain and mental health issues; validate clinical
assessment tools; evaluate outcomes of surgical interventions.
4. Workforce education: identify gaps in health providers’ knowledge, attitudes, and practices; develop and validate educational tools and best practices to train the workforce
across all specialties and training levels.
5. Legal issues: determine the effectiveness of enforcement of federal and state laws on the practice of FGM/C, with particular attention to the consequences of mandatory
reporting laws on physicians, immigrant communities, parents, and at-risk or cut girls.
6. Ethical issues: determine the pressing ethical, moral, legal, and cultural conﬂicts facing physicians, families, and patients and incorporate into nuanced practice
recommendations.
7: Eradication and prevention strategies: systematically evaluate eradication programs’ outcomes data and determine best practices for the eradication and prevention of
FGM/C in the US context.
Note. FGM/C = female genital mutilation or cutting.

of women and girls already affected or at risk. The latest estimate,
from 2012, is that approximately
513 000 women and girls in the
United States had either already
undergone FGM/C or were at
risk for being cut, a substantial
upward readjustment of the 2000
estimate of 228 000.7 This halfmillion estimate is imprecise for
several reasons: it uses countryspeciﬁc, national prevalence statistics and applies them to a unique
segment of a country’s population: migrants living in the
United States. It also conﬂates
women and girls who may have
already been cut with girls who
were born to women from
FGM/C-practicing countries and
may be at risk of being cut.
Further, the estimate only includes immigrants from practicing
African nations and Yemen, as
only those countries’ data were
then available. It does not include
the high prevalence of FGM/C in
other countries that have been
subsequently documented (e.g.,
Indonesia).2 There is a pressing
need to collect accurate data on
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the prevalence of women and girls
living in the United States who
have already been cut, as well as
the incidence of the cutting of girls
from FGM/C-practicing groups
living in the United States, in
order to promulgate policies and
evaluate practices. We also need
to understand the age at which
FGM/C is performed on girls
living in the United States, as well
as how often it is performed here
in America versus in the family’s
country of origin during visits
abroad (“vacation cutting”), who
is doing the cutting, how it is
being carried out, and the types
of FGM/C being performed and
the resulting complications.

Identiﬁcation and
Screening
Education of medical providers
about accurate identiﬁcation of
FGM/C type and appropriate
International Classiﬁcation of Diseases, 10th Revision coding is
critical for the documentation
of prevalence and incidence in
the United States. The accurate
identiﬁcation of FGM/C would
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be greatly facilitated by the development of a visual “atlas,”—
that is, a clinical visual guide.
Several basic atlases exist, the most
recent of which was published
in 20168; however, a more comprehensive atlas would be beneﬁcial. The appearance of scarring
due to FGM/C varies dramatically with age and parity, making
visual guidance invaluable in the
assessment of affected patients. In
addition, there are currently no
visual aids for the assessment of
FGM/C in the pediatric patient.
Recognition of FGM/C is difﬁcult but crucial in this population,
both to provide medical guidance
to girls who have been cut and to
identify at-risk siblings.
Currently, there are no validated screening tools available to
American clinicians. Although
screening tools are available in
other countries,9 including the
widely used British Safeguarding
and Risk Assessment tool10 (which
assesses the risk of girls undergoing
cutting and the medical consequences of FGM/C in girls and
women), they may not be directly

applicable to the United States
given the differences in the health,
social service, and legal systems.
Research is needed to determine
the most appropriate, culturally
sensitive means of screening, as
well as the overall costs and beneﬁts of screening women and girls
from high-prevalence countries
currently residing in the United
States. In addition, development
of a validated screening tool with
which to identify at-risk girls in
pediatric settings is vital to preventing FGM/C from occurring
in the United States or through
vacation cutting.

Clinical Management
There are few evidencebased, comprehensive clinical
management guidelines for the
care of women and girls who
have been subjected to FGM/C.
The American College of Obstetricians and Gynecologists
published an educational resource on FGM/C in 2008;
however, it has not been revised
since then.11 Extensive professional guidance has been

AJPH

November 2019, Vol 109, No. 11

AJPH PERSPECTIVES

developed in the United Kingdom9; however, the applicability
of these recommendations in the
United States has yet to be determined. Most of the international expert recommendations
address obstetrical care, speciﬁcally regarding the timing and
technique for deinﬁbulation.
However, consensus is lacking
with respect to the optimal timing and best surgical technique.
Researchers need to conduct
US-speciﬁc obstetric outcomes
studies investigating deinﬁbulation timing and technique,
delivery techniques and complications, and morbidity and
mortality among mothers and
newborns.
There has been little attention
paid to developing management
recommendations or systematic
guidelines for addressing gynecological and urological pathology and pelvic pain among
affected women, although these
are widely recognized complications of FGM/C.1 Additional
areas suffering from a lack of
systematic, comprehensive evaluation of outcomes include sexual health and function, clitoral
reconstruction, and self-image
related to genital alterations.
Further, the importance of developing nonsurgical techniques,
including physical therapy, for
treating sexual dysfunction
among women with FGM/C
cannot be overemphasized.
Finally, evidence-based best
practices for addressing the
mental health needs of women
and girls living with FGM/C
have yet to be elucidated. There
is evidence that many FGM/Caffected women suffer high
burdens of anxiety, depression, or
posttraumatic stress disorder.12
This is in addition to the psychological consequences among
those who suffer from FGM/Cassociated sexual dysfunction.13
WHO currently recommends
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cognitive behavioral therapy as
the preferred therapeutic modality1; however, a systematic
evaluation of a variety of psychological interventions for affected women and girls is needed.

Workforce Education
Women and girls affected by
FGM/C invariably engage with
a variety of practitioners in the
health care sector, whether
during routine well-woman–
well-child visits, primary care
encounters, and pre-, peri-, and
postpartum appointments, or
as part of the management of
chronic and acute health issues
related to FGM/C. Yet our
literature review reveals that
American medical practitioners
are not sufﬁciently prepared to
care for affected women and
girls.14 There is a need for the
development of FGM/C-related
educational competencies, improved training, better assessments of clinicians’ knowledge
and proﬁciencies, evaluations of
attitudes and practices, appraisals
of communication skills, and the
creation and validation of standardized questionnaires and
assessment tools.
Workforce training has been
studied sporadically in other host
countries, in different specialties,
and at various levels of education.
Multiple published reports address the readiness (or lack
thereof) of host countries’ health
sectors, and their ability to successfully and appropriately manage those affected by FGM/C.
Small studies have assessed the
knowledge, attitudes, and practice of practitioners of various
disciplines, including nurses,
midwives, and physicians, and
from multiple specialties.15
Studies also have assessed the
knowledge, attitudes, and practice of learners at all levels of
health professional education and

show a substantial need and desire
for improved training at all levels
of practice and among different
specialties, including obstetrics
and gynecology.16,17
Ultimately, research into educational interventions regarding
FGM/C should aim to produce
robust curricula for US health
professionals at all levels of education, identify educational best
practices, and disseminate highquality training programs for
multiple specialties. Women and
girls with FGM/C seek care from
a number of different specialists,
including not only obstetrician–
gynecologists and midwives but
also pediatricians, family physicians, nurse practitioners, physician’s assistants, emergency
medicine physicians, dermatologists, plastic surgeons, and urologists, all of whom need baseline
knowledge regarding FGM/C
and its management.

Legal Issues
FGM/C is considered a universal human rights violation.1
In 1996, Congress passed the
Federal Prohibition of Female
Genital Mutilation Act, which
made it illegal to perform FGM/C
in the United States on anyone
younger than 18 years.18 In 2013,
the federal law was amended
to include a provision banning
vacation cutting, which prohibits knowingly transporting or
attempting to send a girl younger
than 18 years outside the United
States to undergo FGM/C. The
federal law was recently declared
unconstitutional by a Michigan
federal judge; as of this writing,
several attempts at both state and
congressional levels are under
way to address this decision.19 This
resultant period of uncertainty will
no doubt serve to further confuse
many who work with FGM/Caffected populations. Anecdotal
evidence from expert meetings

and a study of obstetrician–
gynecologists by Moaddab et al.
suggest that many US health care
providers were unaware of
existing legislation prohibiting
FGM/C—before the Michigan
ruling.17
With the challenge to the
federal law, individual state laws
are bound to become critical in
efforts to outlaw and curb this
practice. To date, 35 states
have speciﬁc laws prohibiting
FGM/C,20 including seven states
that explicitly ban vacation cutting. State laws, however, differ
with regard to the age at which
the FGM/C prohibition applies,
the individuals who are subject
to prosecution, the penalties
for performing FGM/C, and
whether religion or culture
can be used as a defense of the
practice. Some states, moreover,
establish explicit mandatory
reporting duties for health care
providers and other professionals.
In all 50 states, child abuse statutes
deﬁne either “physical abuse” or
“sexual abuse” in such a manner
that they arguably encompass
FGM/C. As a result, health care
providers—as mandated reporters of child abuse—have a
duty to report cases of FGM/C
among patients younger than 18
years to the authorities.
The existence of FGM/C
laws does not necessarily mean
that they are implemented or
enforced. There is little to no
information about the effectiveness
of enforcement of state FGM/C
laws on immigrant populations,
or about how criminalization
affects trends regarding FGM/C
acceptance and practice. Many
experts believe that law enforcement should go hand in
hand with culturally sensitive
approaches to educating practicing migrant communities,
as well as educating those in
law enforcement who may
come in contact with them.
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Cross-sectoral medical and legal
collaboration is required to assess
some critical interdisciplinary issues, including the following:
What will be the consequences
of overturning the federal law?
What are the effects or unintended consequences of mandatory reporting laws? What are
the effects of the criminalization
of FGM/C on parents’ behaviors
and patients’ disclosures and on
immigrant communities’ attitudes and behaviors? What are
the effects on children if they are
removed from their parents because they were cut?

Ethical Issues
Health care providers’ behavior and decision-making in
the clinical setting are shaped by a
variety of issues, including professional guidelines, legal obligations, personal morals, cultural
biases, and medical ethics. Clinicians can face a number of
conﬂicts regarding medical,
moral, ethical, and legal obligations surrounding professional
duty, obligations to the patient,
respect for autonomy and culture, human rights, and regard for
laws, regulations, and policies.
Clinical recommendations
about FGM/C rarely address the
interplay of these complex issues.
For example, there is ambiguity
surrounding reinﬁbulation in a
consenting adult woman.21 Mandatory reporting requirements
can present physicians with ethically fraught situations related to
dual loyalties—for example, supporting well-meaning parents and
preserving an intact family versus
upholding the demands of the
state and potentially causing the
removal of a child from a loving
family. Suspicions regarding the
risk of vacation cutting in particular raise ethical dilemmas.22
Other dilemmas include consideration of “ritual nicks” as a
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compromise type of FGM/C23
and the ethical difference between
FGM/C and cosmetic labiaplasty,24 as well as the medicalization of FGM/C as a means of
harm reduction.25,26 Clinical
guidelines should incorporate the
interplay of moral, ethical, legal,
and patient-oriented perspectives.

Eradication and
Prevention Strategies
FGM/C is a complex phenomenon and has different signiﬁcance and meaning among
the various cultural and ethnic
groups who practice it. Years of
international efforts to eliminate FGM/C have resulted in
a signiﬁcant decline in overall
prevalence in some countries;
however, it remains a pervasive
practice in others, and evidencebased prevention and intervention
strategies that are culturally and
religiously sensitive remain a
public health priority.27 Prevention and eradication in the
United States is complicated by
the mixing of multiple practicing
ethnic groups who differ in language, culture, and traditions. To
formulate effective strategies, it is
essential to systematically evaluate outcomes data of FGM/C
eradication programs, both in the
United States and abroad. Eradication and prevention of FGM/C
will ultimately occur at the
intersection of public education,
professional advocacy, policy
enactment, judicial action, and
community engagement.

CONCLUSIONS
FGM/C is gaining recognition
as an important public health issue
in the United States. With rapid
growth in the numbers of immigrants from FGM/C-practicing
countries living in America, health
care providers will invariably
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encounter women and girls who
have undergone or are at risk for
cutting. There is an urgent need
to undertake a comprehensive research agenda to address the major
gaps in knowledge and establish
more rigorous evidence-based interventions to address FGM/C’s
manifestations and complications,
as well as to deliver compassionate,
culturally sensitive care to the
hundreds of thousands of affected
women and girls residing in the
United States.
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